Micron Technology (MU) 10-K: FY26 revenue jumps to $133.2B (Oct 9, 2026)

Consolidated Balance Sheets 68 Consolidated Statements of Changes in Equity 69 Consolidated Statements of Cash Flows 70 Notes to Consolidated Financial Statements 71 Report of Independent Registered Public Accounting Firm (PCAOB ID 238) 95 66 Table of Contents Micron Technology, Inc. Consolidated Statements of Operations and Comprehensive Income (In millions, except per share amounts) For the year endedSeptember 3, 2026August 28, 2025August 29, 2024 Revenue$133,188 $37,378 $25,111 Cost of goods sold25,684 22,505 19,498 Gross margin107,504 14,873 5,613 Research and development5,650 3,798 3,430 Selling, general, and administrative1,947 1,205 1,129 Other operating (income) expense, net567 100 (250) Operating income99,340 9,770 1,304 Interest income1,084 496 529 Interest expense(106)(477)(562) Other non-operating income (expense), net(647)(135)(31) 99,671 9,654 1,240 Income tax (provision) benefit(14,761)(1,124)(451) Equity in net income (loss) of equity method investees 59 9 (11) Net income$84,969 $8,539 $778 Other comprehensive income (loss), net of tax(41)102178 Total comprehensive income$84,928 $8,641 $956 Earnings per share Basic$75.38 $7.65 $0.70 Diluted74.33 7.59 0.70 Number of shares used in per share calculations Basic1,127 1,116 1,105 Diluted1,143 1,125 1,118 See accompanying notes to consolidated financial statements. 67 | 2026 10-K Table of Contents Micron Technology, Inc. Consolidated Balance Sheets (In millions, except par value amounts) As ofSeptember 3, 2026August 28, 2025 Assets Cash and cash equivalents $38,364 $9,642 Short-term investments5,070 665 Receivables36,197 9,265 Inventories10,372 8,355 Other current assets1,067 914 Total current assets91,070 28,841 Long-term marketable investments30,019 1,629 Property, plant, and equipment63,310 46,590 Goodwill1,150 1,150 Other noncurrent assets10,339 4,588 Total assets$195,888 $82,798 Liabilities and equity Accounts payable and accrued expenses$22,605 $9,649 Current debt491 560 Other current liabilities4,386 1,245 Total current liabilities27,482 11,454 Long-term debt4,688 14,017 Noncurrent unearned government incentives786 1,018 Noncurrent customer contract liabilities12,895 142 Other noncurrent liabilities11,659 2,002 Total liabilities57,510 28,633 Commitments and contingencies Shareholders equity Common stock, $0.10 par value, 3,000 shares authorized, 1,277 shares issued and 1,131 outstanding (1,266 shares issued and 1,122 outstanding as of August 28, 2025) 128 127 Additional capital14,974 13,339 Retained earnings131,851 48,583 Treasury stock, 146 shares held (144 shares as of August 28, 2025) (8,502)(7,852) Accumulated other comprehensive income (loss)(73)(32) Total equity138,378 54,165 Total liabilities and equity$195,888 $82,798 See accompanying notes to consolidated financial statements. 68 Table of Contents Micron Technology, Inc. Consolidated Statements of Changes in Equity (In millions, except per share amounts) Common StockAdditional CapitalRetained EarningsTreasury StockAccumulated Other Comprehensive Income (Loss)Total Shareholders Equity Number of SharesAmount Balance as of August 31, 20231,239$124 $11,036 $40,824 $(7,552)$(312)$44,120 Net income 778 778 Other comprehensive income (loss), net 178 178 Stock issued under equity compensation plans 171 271 272 Stock-based compensation expense 833 833 Repurchase of stock repurchase program (300) (300) Repurchase of stock withholdings on employee equity awards (3) (25)(207) (232) Dividends and dividend equivalents declared ($0.460 per share) (518) (518) Balance as of August 29, 20241,253$125 $12,115 $40,877 $(7,852)$(134)$45,131 Net income 8,539 8,539 Other comprehensive income (loss), net 102 102 Stock issued under equity compensation plans 162 285 287 Stock-based compensation expense 972 972 Repurchase of stock withholdings on employee equity awards (3) (33)(306) (339) Dividends and dividend equivalents declared ($0.460 per share) (527) (527) Balance as of August 28, 20251,266$127 $13,339 $48,583 $(7,852)$(32)$54,165 Net income 84,969 84,969 Other comprehensive income (loss), net (41)(41) Stock issued under equity compensation plans 141 336 337 Stock-based compensation expense 1,333 1,333 Repurchase of stock repurchase program (650) (650) Repurchase of stock withholdings on employee equity awards (3) (34)(1,093) (1,127) Dividends and dividend equivalents declared ($0.530 per share) (608) (608) Balance as of September 3, 20261,277$128 $14,974 $131,851 $(8,502)$(73)$138,378 See accompanying notes to consolidated financial statements. 69 | 2026 10-K Table of Contents Micron Technology, Inc. Consolidated Statements of Cash Flows (In millions)September 3, 2026August 28, 2025August 29, 2024$84,969 $8,539 $778 9,503 8,352 7,780 1,333 972 833 (25,206)(1,776)(3,581)(2,017)520 (488)8,707 862 1,915 3,141 (272)989 9,633 381 76 (388)(53)205 89,675 17,525 8,507 (34,871)(1,890)(1,999)(30,712)(15,857)(8,386)(1,046)(34)(10)3,316 2,005 315 1,988 1,698 1,794 (316)(9)(23)(61,641)(14,087)(8,309)12,747 4,430 999 (10,043)(4,619)(1,897)(1,127)(340)(233)(650) (300)(610)(522)(513)313 201 102 630 (850)(1,842)81 6 40 28,745 2,594 (1,604)9,646 7,052 8,656 $38,391 $9,646 $7,052 $(1,254)$(583)$(338)(197)(418)(503)143 1,298 905 As of August 28, 2025 Cash and Cash Equivalents Short-term InvestmentsLong-term Marketable Investments(1) Total Fair ValueCash and Cash Equivalents Short-term InvestmentsLong-term Marketable Investments(1) Total Fair Value Cash$26,288 $ $ $26,288 $7,875 $ $ $7,875 Level 1(2) Money market funds216 216 410 410 Level 2(3) Certificates of deposit9,814 59 9,873 1,292 6 1,298 Corporate bonds97 3,773 24,557 28,427 23 559 1,047 1,629 Asset-backed securities 221 5,391 5,612 31 521 552 Commercial paper1,674 971 2,645 33 26 59 Government securities275 46 71 392 9 43 61 113 38,364 $5,070 $30,019 $73,453 9,642 $665 $1,629 $11,936 Restricted cash(4) 27 4 Cash, cash equivalents, and restricted cash$38,391 $9,646 (1)The maturities of long-term marketable investments primarily range from one to five years, except for asset-backed securities which are not due at a single maturity date. (2)The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3)The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of September 3, 2026 or August 28, 2025. (4)Restricted cash is included in other current assets. Gross realized gains and losses from sales of available-for-sale securities were not material for any period presented. 75 | 2026 10-K Table of Contents Non-marketable Equity Investments In addition to the amounts included in the table above, we had $1.30 billion and $194 million of non-marketable equity investments without a readily determinable fair value that were included in other noncurrent assets as of September 3, 2026 and August 28, 2025, respectively. Our non-marketable investments were primarily held in AI and technology companies. Gains and losses related to our non-marketable investments were not material for any period presented. Our non-marketable equity investments are carried at cost less impairment, if any, adjusted for qualifying observable price changes. Note 5. Receivables As ofSeptember 3, 2026August 28, 2025 Trade receivables$31,793 $7,163 Government incentives 3,319 1,572 Income and other taxes635 436 Other450 94 $36,197 $9,265 Note 6. Inventories As ofSeptember 3, 2026August 28, 2025 Finished goods$958 $1,094 Work in process8,252 6,401 Raw materials and supplies1,162 860 $10,372 $8,355 Note 7. Property, Plant, and Equipment As ofSeptember 3, 2026August 28, 2025 Land$420 $420 Buildings26,493 22,173 Equipment(1) 93,954 79,934 Construction in progress(2) 11,424 5,518 Software1,885 1,651 134,176 109,696 Accumulated depreciation(70,866)(63,106) $63,310 $46,590 (1)Includes costs related to equipment not placed into service of $6.12 billion as of September 3, 2026 and $4.05 billion as of August 28, 2025. (2)Primarily includes building-related construction and tool installation. 76 Table of Contents The carrying value of our finance lease right-of-use assets included in property, plant, and equipment was $2.40 billion and $3.00 billion as of September 3, 2026 and August 28, 2025, respectively. In March 2026, we completed the acquisition of a wafer fabrication facility in Tongluo, Miaoli County, Taiwan, from Powerchip Semiconductor Manufacturing Corporation for total cash consideration of $1.80 billion. Depreciation expense was $9.42 billion, $8.28 billion, and $7.70 billion for 2026, 2025, and 2024, respectively. Interest capitalized as part of the cost of property, plant, and equipment was $383 million, $321 million, and $225 million for 2026, 2025, and 2024, respectively. Note 8. Accounts Payable and Accrued Expenses As ofSeptember 3, 2026August 28, 2025 Accounts payable$3,518 $3,132 Property, plant, and equipment8,618 4,391 Income and other taxes5,626 628 Salaries, wages, and benefits4,447 1,116 Other396 382 $22,605 $9,649 Note 9. Debt As of September 3, 2026As of August 28, 2025 Net Carrying AmountNet Carrying Amount Stated RateEffective RatePrincipalCurrentLong-TermTotalPrincipalCurrentLong-TermTotal 2032 Green Bonds2.703 %2.77 %$1,000 $ $997 $997 $1,000 $ $996 $996 2032 Notes 5.650 %5.79 %71 70 70 500 496 496 2033 A Notes5.875 %5.96 %176 175 175 750 746 746 2033 B Notes5.875 %6.01 %215 213 213 900 892 892 2035 A Notes5.800 %5.90 %136 135 135 1,000 992 992 2035 B Notes6.050 %6.14 %220 219 219 1,250 1,241 1,241 2041 Notes3.366 %3.41 %500 497 497 500 497 497 2051 Notes3.477 %3.52 %490 486 486 500 496 496 2028 NotesN/AN/A 542 540 540 2029 Term Loan AN/AN/A 984 982 982 2029 A NotesN/AN/A 700 698 698 2029 B NotesN/AN/A 1,159 1,168 1,168 2030 Notes N/AN/A 796 794 794 2031 Notes N/AN/A 1,000 995 995 Finance lease liabilitiesN/A4.71 %2,387 491 1,896 2,387 3,044 560 2,484 3,044 $5,195 $491 $4,688 $5,179 $14,625 $560 $14,017 $14,577 As of September 3, 2026, all of our debt, other than finance lease liabilities, were unsecured obligations that rank equally in right of payment with all of our other existing and future unsecured indebtedness and were effectively subordinated to all future secured indebtedness, to the extent of the value of the assets securing such indebtedness. All our unsecured debt were obligations of our parent company, Micron, and were structurally subordinated to all liabilities of its subsidiaries, including trade payables. The terms of our indebtedness generally contain cross payment default and cross acceleration provisions. Micron s guarantees of certain liabilities of its subsidiaries are unsecured obligations ranking equally in right of payment with all of Micron s other existing and future unsecured indebtedness. 77 | 2026 10-K Table of Contents The fair value of our outstanding notes payable was $2.43 billion as of September 3, 2026, and $11.57 billion as of August 28, 2025. The fair value of our debt instruments was estimated based on Level 2 inputs, including the trading price of our notes when available, discounted cash flows, and interest rates based on similar debt issued by parties with credit ratings similar to ours. Debt Activity The table below presents the effects of prepayment activities in 2026: Transaction DateDecrease in PrincipalDecrease in Carrying ValueDecrease in Cash Prepayments 2028 NotesOctober 24, 2025$(542)$(541)$(562) 2029 B NotesOctober 24, 2025(1,159)(1,168)(1,276) 2029 Term Loan AOctober 27, 2025(984)(982)(984) 2051 NotesJanuary 23, 2026(10)(10)(7) 2029 A NotesFebruary 20, 2026(700)(698)(726) 2030 NotesFebruary 23, 2026(796)(794)(816) 2031 NotesApril 3, 2026(738)(734)(773) 2032 NotesApril 3, 2026(429)(426)(456) 2033 A NotesApril 3, 2026(574)(571)(616) 2033 B NotesApril 3, 2026(685)(679)(734) 2035 A NotesApril 3, 2026(864)(857)(921) 2035 B NotesApril 3, 2026(1,030)(1,022)(1,114) 2031 NotesJuly 27, 2026(262)(261)(270) $(8,773)$(8,743)$(9,255) In connection with these prepayments, we recognized losses in other non-operating income (expense) of $510 million for 2026. Senior Unsecured Notes We may redeem our 2032 Green Bonds, 2032 Notes, 2033 A Notes, 2033 B Notes, 2035 A Notes, 2035 B Notes, 2041 Notes, and 2051 Notes (the Senior Unsecured Notes ), in whole or in part, at a redemption price equal to the greater of (i) 100% of the principal amount of the notes to be redeemed and (ii) the present value of the remaining scheduled payments of principal and interest, plus, in each case, accrued interest. We may also redeem any series of the Senior Unsecured Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued interest between two and six months prior to the applicable maturity date, in accordance with the respective terms of such series. The Senior Unsecured Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock and which own principal property, as defined in the indenture governing the Senior Unsecured Notes) to (1) create or incur certain liens; (2) enter into certain sale and lease-back transactions with respect to any principal property; and (3) consolidate with or merge with or into, or convey, transfer, or lease all or substantially all of our properties and assets, to another entity. These covenants are subject to a number of limitations and exceptions. Additionally, if a change of control triggering event occurs, as defined in the indenture governing each series of the Senior Unsecured Notes, we will be required to offer to repurchase the Senior Unsecured Notes of such series at a price equal to 101% of the principal amount plus accrued interest up to the repurchase date. 78 Table of Contents Finance Lease Liabilities Our finance leases consist primarily of (1) equipment leases and (2) gas and other supply agreements that are deemed to contain embedded leases. Certain supply or service agreements require us to exercise judgment to determine whether the agreement contains a lease. Our assessment includes determining whether we or the supplier control the assets used to fulfill the agreements. Our gas supply arrangements generally are deemed to contain a lease because we have the right to substantially all of the output of the assets used to produce the supply and we have the right to change the quantity and timing of the output of those assets. Our finance lease liabilities had a weighted-average expected term of seven years as of September 3, 2026 and August 28, 2025. Certain third-party special purpose entities (the Lease SPEs ) facilitate equipment lease financing transactions between us and various financial institutions. Neither we nor the financial institutions have an equity interest in the Lease SPEs, which are variable interest entities. The arrangements are financing vehicles and we do not bear any significant risks from variable interests with the Lease SPEs. We do not have the power to direct the activities of the Lease SPEs that most significantly impact their economic performance and, as such, we do not consolidate them. We had approximately $1.02 billion and $1.58 billion of finance lease liabilities and right-of-use assets under these arrangements as of September 3, 2026 and August 28, 2025, respectively. Revolving Credit Facility On May 6, 2026, we reduced our borrowing capacity under the Revolving Credit Facility from $3.50 billion to $2.00 billion. As of September 3, 2026, no amounts were outstanding under the Revolving Credit Facility. Borrowing under the Revolving Credit Facility would generally bear interest at a rate equal to adjusted term SOFR plus 0.875% to 1.50%, depending on our corporate credit ratings. Any amounts outstanding under the Revolving Credit Facility would mature on March 12, 2030 and amounts borrowed may be prepaid without penalty. Any obligations under the Revolving Credit Facility would be unsecured. The Revolving Credit Facility requires us to maintain, on a consolidated basis, a net leverage ratio of total net indebtedness to adjusted EBITDA, as defined in the Revolving Credit Facility agreement and calculated as of the last day of each fiscal quarter, not to exceed 3.25 to 1.00, subject to a temporary four fiscal quarter increase in such maximum ratio to 3.75 to 1.00 following certain material acquisitions. Maturities of Notes Payable and Finance Lease Liabilities As of September 3, 2026, maturities of notes payable and finance lease liabilities by fiscal year were as follows: Notes PayableFinance Leases 2027$ $577 2028 560 2029 500 2030 349 2031 130 2032 and thereafter2,808 659 Discounts and imputed interest, respectively(16)(388) $2,792 $2,387 79 | 2026 10-K Table of Contents Note 10. Commitments As of September 3, 2026, we had noncancelable commitments with remaining contractual terms in excess of one year of approximately $10.8 billion for purchase obligations, of which approximately $1.3 billion will be due in 2027, $1.8 billion due in 2028, $1.4 billion due in 2029, $1.1 billion due in 2030, $800 million due in 2031, and $4.4 billion due in 2032 and thereafter. Purchase obligations primarily include payments for goods or services with either a fixed or minimum quantity and price, which includes payments for the acquisition of property, plant, and equipment. Payments for finance leases for gas supply arrangements deemed to contain embedded leases that have been executed but have not yet commenced are also included. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use. Note 11. Contingencies We are currently a party to legal actions other than those described below arising from the normal course of business, none of which are expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. A description of certain claims is below. On April 28, 2021, Netlist, Inc. ( Netlist ) filed two patent infringement actions against Micron, Micron Semiconductor Products, Inc. ( MSP ), and Micron Technology Texas, LLC ( MTEC ) in the U.S. District Court for the Western District of Texas ( W.D. Tex. ). On March 31, 2022, Netlist filed a patent infringement complaint against Micron and Micron Semiconductor (Deutschland) GmbH ( MSG ) in D sseldorf Regional Court alleging that two German patents are infringed by certain of our load-reduced dual in-line memory modules ( LRDIMMs ). The complaint seeks damages, costs, and injunctive relief. 80 Table of Contents On June 10, 2022, Netlist filed a patent infringement complaint against Micron, MSP, and MTEC in the U.S. District Court for the Eastern District of Texas ( E.D. Tex. ) alleging that six U.S. patents are infringed by certain of our memory modules and HBM products. On August 1, 2022, Netlist filed a second patent infringement complaint against the same defendants in E.D. Tex. alleging that one U.S. patent is infringed by certain of our LRDIMMs. Additional patents were added by subsequent amendments to the complaint. The complaints in E.D. Tex. seek injunctive relief, damages, and attorneys fees. On May 19, 2025, Netlist filed a complaint against Micron, MSP, and MTEC in E.D. Tex. alleging that one U.S. patent is infringed by our HBM products. On March 6, 2026, the E.D. Tex. transferred the case to the U.S. District Court for the District of Delaware ( D. Del. ) pursuant to a motion by Micron to dismiss or transfer for improper venue. On July 28, 2025, Netlist filed an additional complaint against Micron, MSP, and MTEC in E.D. Tex. alleging that one U.S. patent is infringed by certain of our DIMMs. On June 23, 2026, Netlist filed a counterclaim against Micron and MSP in D. Del. alleging that one U.S. patent is infringed by our HBM products. The counterclaim seeks damages, attorneys fees, and other equitable relief. On August 10, 2026, Netlist filed a complaint against Micron and MSP in the U.S. District Court for the Central District of California ( C.D. Cal.:) alleging that two U.S. patents are infringed by certain of our DIMMs. On August 10, 2026, Netlist filed a complaint to the U.S. International Trade Commission ( ITC ) requesting the ITC to institute an investigation under Section 337 of the Tariff Act of 1930 for patent infringement. The ITC instituted an investigation on September 23, 2026. Netlist s complaint alleges that four U.S. patents are infringed by certain of our DRAM products and seeks an exclusion order barring importation of such products. On October 5, 2026, Netlist and Micron agreed to dismiss all litigation claims against one another pursuant to settlement and license agreements. On January 23, 2023, BeSang Inc. filed a patent infringement complaint against Micron in E.D. Tex. The complaint alleges that one U.S. patent is infringed by certain of our 3D NAND and SSD products. The complaint seeks an injunction, damages, attorneys fees, and costs. On September 17, 2025, the District Court issued a judgment that the accused products do not infringe the asserted patent. On October 17, 2025, BeSang filed a notice of appeal of the District Court s judgment. On November 9, 2023, Yangtze Memory Technologies Company, Ltd. ( YMTC ) filed a patent infringement complaint against Micron and one of its subsidiaries in the U.S. District Court for the Northern District of California ( N.D. Cal. ). The complaint alleges that eight U.S. patents are infringed by certain of our 3D NAND products. The complaint seeks an injunction, damages, attorneys fees, and costs. On January 22, 2024, Micron Semiconductor (Shanghai) Co., Ltd. ( MSS ) was served with three patent infringement complaints filed by YMTC in Beijing Intellectual Property Court and on February 27, 2024, Micron was served with the same complaints. The complaints assert that Micron and MSS infringed three Chinese patents owned by YMTC by importing, selling, offering for sale, and assisting others to sell certain 3D NAND products and SSDs in China. The complaint seeks an injunction, damages, attorneys fees, and costs. On July 12, 2024, YMTC filed a second complaint against Micron and its subsidiary in N.D. Cal. The second complaint alleges that eleven U.S. patents are infringed by certain of our 3D NAND and DDR5 DRAM products. The complaint seeks an injunction, damages, attorneys fees, and costs. On September 11, 2024, MSS was served with five patent infringement complaints filed by YMTC in Shanghai Intellectual Property Court. The complaints assert that Micron and MSS infringed five Chinese patents owned by YMTC by importing, selling, offering for sale, and assisting others to sell certain 3D NAND products and SSDs in China. The complaint seeks an injunction, damages, attorneys fees, and costs. 81 | 2026 10-K Table of Contents On October 6, 2025, YMTC filed several patent infringement complaints against Micron and certain of its subsidiaries alleging that the Company s manufacture, importation, sale, offering for sale, and/or assisting others to sell certain NAND and DRAM products infringe certain patents owned by YMTC. Specifically, YMTC filed the following complaints: A patent infringement complaint against Micron, MSP, and MTEC in E.D. Tex. alleging that seven patents are infringed by certain of our 3D NAND products and one patent is infringed by certain of our LPDRAM products; a patent infringement complaint in the London Chancery Division of the English High Court against Micron and Micron Europe Limited ( MEL ) alleging that three patents are infringed by certain of our NAND and DRAM products; three complaints against Micron and various combinations of subsidiaries, including MEL, MSP, MSG, and Micron Semiconductor France SAS in the Unified Patent Court in Dusseldorf, Germany, alleging that three patents are infringed by certain of our 3D NAND and LPDRAM products; and five complaints against Micron, MEL, and MSG in Munich Regional Court in Munich, Germany, alleging that four utility models and one patent are infringed by certain of our 3D NAND products. Each of the complaints filed against us by YMTC on October 6, 2025, seeks an injunction, attorneys fees, damages, and costs. On September 17 and 18, 2026, the Munich Regional Court held a hearing regarding infringement of the asserted utility models and patent. At the conclusion of the hearing, the court indicated that it would find that certain of Micron s 3D NAND products infringe two of the asserted utility models. On October 6, 2026, the court issued written rulings requiring Micron to cease and desist offering, marketing, importing, or possessing the accused 3D NAND products in Germany and to stop deliveries of products abroad to customers where Micron knows or has clear indications the customer will supply the products into Germany; to provide an accounting regarding alleged infringing acts; and to surrender accused products located in Germany unless already incorporated into third parties end devices. The court further indicated that additional proceedings will be held in June and September 2027 regarding the other two asserted utility models and the asserted patent. Micron has appealed the infringement ruling regarding the two utility models. On June 30, 2025, Advanced Memory Technologies, LLC ( AMT ) filed a patent infringement complaint against Micron in W.D. Tex. alleging that four U.S. patents are infringed by certain of our DRAM and NAND products. On November 4, 2025, AMT amended the complaint to allege that a fifth patent is infringed by certain of our DRAM products. The complaint seeks an injunction, damages, attorneys fees, and costs. On July 6, 2026, the case was transferred to the U.S. District Court for the District of Idaho ( D. Idaho ). On March 6, 2026, Nextech Semiconductor, LLC ( Nextech ) filed a patent infringement complaint against Micron and MSP in W.D. Tex. alleging that six U.S. patents are infringed by certain of our DRAM, NAND, and SSD products. The complaint seeks an injunction, damages, attorneys fees, and costs. The above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for substantially all of our revenue. Antitrust Matters On June 25, 2026, certain individuals and businesses filed a putative class action complaint in N.D. Cal. against Micron, Samsung Electronics Co., Ltd. and one of its subsidiaries, and SK hynix Inc. and one of its subsidiaries, on behalf of a putative class of purchasers of DRAM products, alleging that the defendants conspired to restrict the supply of, and fix prices for, DRAM products in violation of the Sherman Act and various state antitrust and consumer protection laws, for a period beginning October 26, 2022. The complaint seeks damages, treble damages, injunctive relief, attorneys fees, and costs. On July 17, 2026, an individual filed a complaint containing similar allegations of conspiracy against the same defendants in the U.S. District Court for the District of Hawaii. 82 Table of Contents Other Matters On June 7, 2025, YMTC filed a complaint against Micron and DCI Group AZ, LLC in the U.S. District Court for the District of Columbia. The complaint alleges that the defendants engaged in false advertising, product disparagement, and unfair competition regarding YMTC s 3D NAND flash products in violation of the Lanham Act. The complaint sought injunctive relief, damages, disgorgement of profits, attorneys fees, and costs. On August 13, 2026, the District Court granted the defendants motions to dismiss YMTC s complaint. On August 24, 2026, YMTC filed a notice of appeal to the U.S. Court of Appeals for the District of Columbia Circuit. On January 16, 2026, Neighbors for a Better Micron and Jobs to Move America filed a petition in the Supreme Court of New York against Micron, one of our subsidiaries, Onondaga County Industrial Development Agency ( OCIDA ), and certain other state and local government entities. The petition challenges certain aspects of OCIDA s environmental review of the Company s planned construction of up to four fabs in Clay, New York, and seeks a judgment to annul, vacate, and void all permits, approvals, and findings issued by the named government entities related to the project. The petition further seeks costs and attorneys fees. On July 31, 2026, the same plaintiffs filed a petition in the Supreme Court of New York against the same defendants challenging certain permits issued for Micron s construction related activities in Clay, New York. The petition seeks a judgment to annul, vacate and void such permits and an award to the petitioners of costs and attorneys fees. In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify another party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition. Contingency Assessment Except for the patent license charges recognized in the fourth quarter of 2026, we are unable to predict the outcome of any of the matters noted above and cannot make a reasonable estimate of the potential loss or range of possible losses. See Note 17. Other Operating (Income) Expense, Net. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition. Note 12. Equity Common Stock Repurchases In 2018, our Board of Directors authorized a stock repurchase program for the discretionary repurchase of up to $10 billion (the 2018 authorization ) of our outstanding common stock through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans and on October 8, 2026 our Board of Directors authorized an increase in the maximum amount of discretionary repurchases of our outstanding common stock to be made from December 9, 2026 to $35.16 billion. Any repurchases made will be in accordance with our CHIPS Act direct funding agreements. Our stock repurchase program and the new authorization have no expiration date, do not obligate us to acquire any common stock, and are subject to market conditions, restrictions applicable under our CHIPS Act direct funding agreements, and our ongoing determination of the best use of available cash. See Note 15. Government Incentives. We repurchased 2.5 million shares of our common stock for $650 million in 2026. No shares were repurchased in 2025. Through September 3, 2026, we had repurchased an aggregate of $7.84 billion under the 2018 authorization. Amounts repurchased are included in treasury stock. 83 | 2026 10-K Table of Contents Dividends We declared and paid dividends of $0.115 per share in the first and second quarters of 2026 and $0.15 per share in the third and fourth quarters of 2026. On September 30, 2026, our Board of Directors declared a quarterly dividend of $0.15 per share, payable in cash on October 29, 2026, to shareholders of record as of the close of business on October 14, 2026. Note 13. Derivative Instruments Notional or Contractual AmountFair Value(1) of Assets(2) Liabilities(3) As of September 3, 2026 Derivative instruments with hedge accounting designation Cash flow currency hedges $4,429 $28 $(80) Cash flow commodity hedges446 85 (9) Fair value currency hedges 11,493 1 (21) Derivative instruments without hedge accounting designation Non-designated currency hedges 20,148 38 (57) $152 $(167) As of August 28, 2025 Derivative instruments with hedge accounting designation Cash flow currency hedges $3,271 $41 $(64) Cash flow commodity hedges393 19 (20) Fair value currency hedges3,049 1 (10) Derivative instruments without hedge accounting designation Non-designated currency hedges 3,477 3 (18) $64 $(112) (1)Forward and swap contracts are measured at fair value based on market-based observable inputs including market spot and forward rates, interest rates, and credit-risk spreads (Level 2). (2)Included in receivables and other noncurrent assets. (3)Included in accounts payable and accrued expenses and other noncurrent liabilities. Derivative Instruments with Hedge Accounting Designation Cash Flow Hedges: We utilize forward and swap contracts that generally mature within two years designated as cash flow hedges to minimize our exposure to changes in currency exchange rates or commodity prices for certain capital expenditures and manufacturing costs. Fair Value Hedges: We utilize currency forward contracts that generally mature within one year designated as fair value hedges to minimize our exposure to changes in currency exchange rates for non-U.S.-dollar-denominated cash and investments in debt securities. The fair value of our hedged cash and investments in debt securities was $11.51 billion and $3.05 billion as of September 3, 2026 and August 28, 2025, respectively. The changes in the fair values of derivatives designated as fair value hedges and the offsetting changes in the underlying fair values of the hedged items are both recognized in earnings. 84 Table of Contents Derivative Instruments without Hedge Accounting Designation Currency Derivatives: We generally utilize a rolling hedge strategy with currency forward contracts that mature within one year to hedge our exposures of monetary assets and liabilities from changes in currency exchange rates. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Realized and unrealized gains and losses on derivative instruments without hedge accounting designation, as well as the changes in the underlying monetary assets and liabilities from changes in currency exchange rates, are included in other non-operating income (expense), net. Gains and losses from our derivative instruments were not material for the periods presented. Derivative Counterparty Credit Risk and Master Netting Arrangements Our derivative instruments expose us to credit risk to the extent counterparties may be unable to meet the terms of the contracts. Our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts would generally equal the fair value of assets for these contracts as listed in the tables above. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple financial institutions. As of September 3, 2026 and August 28, 2025, amounts netted under our master netting arrangements were not material. Note 14. Equity Compensation Plans As of September 3, 2026, 47 million shares of our common stock were available for future awards under our equity compensation plans, including 6 million shares approved for issuance under our employee stock purchase plan ( ESPP ). Restricted Stock and Restricted Stock Units ( Restricted Stock Awards ) As of September 3, 2026, there were 19 million shares of Restricted Stock Awards outstanding, 16 million of which are only subject to service-based vesting conditions. Service-based Restricted Stock Awards generally vest on 25% of the units granted after the first year and on 6.25% each quarter thereafter over the remaining three years of employment. Restricted Stock Awards with performance or market-based vesting conditions vest over a three-year period as conditions are met. At the end of the performance period, the number of actual shares to be awarded will vary between 0% and 200% of target amounts, depending upon the achievement level. Our unvested restricted stock awards generally include dividend equivalent rights. Restricted Stock Awards activity for 2026 is summarized as follows: Number of SharesWeighted-Average Grant Date Fair Value Per Share Outstanding as of August 28, 2025 25 $82.12 Granted7 243.13 Vested (12)76.24 Forfeited (1)103.43 Outstanding as of September 3, 202619 144.38 For the year ended202620252024 Restricted stock award shares granted71113 Weighted-average grant-date fair value per share$243.13 $101.15 $72.72 Aggregate vesting-date fair value of shares vested $4,846 $1,322 $1,008 85 | 2026 10-K Table of Contents Employee Stock Purchase Plan ( ESPP ) Our ESPP is offered to substantially all employees and permitted eligible employees to purchase shares of our common stock through payroll deductions of up to 15% of their eligible compensation, subject to certain limitations. The purchase price of the shares under the ESPP equals 85% of the lower of the fair market value of our common stock on either the first or last day of each six-month offering period. Under the ESPP, employees purchased 2 million shares of common stock in 2026, and 4 million shares of common stock in each of 2025 and 2024. Stock-based Compensation Expense For the year ended202620252024 Stock-based compensation expense by caption Cost of goods sold$528 $409 $312 Research and development495 347 296 Selling, general, and administrative259 219 213 $1,282 $975 $821 Stock-based compensation expense by type of award Restricted stock awards$1,153 $877 $749 ESPP129 98 72 $1,282 $975 $821 Income tax benefits related to the tax deductions for share-based awards are recognized only upon the settlement of the related share-based awards. Income tax benefits for share-based awards were $633 million, $163 million, and $140 million for 2026, 2025, and 2024, respectively. The capitalized stock-based compensation expense that remained in inventory was not material for any period presented. As of September 3, 2026, $1.98 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the fourth quarter of 2030, resulting in a weighted-average period of 1.2 years. Note 15. Government Incentives We receive incentives from governmental entities primarily in India, Japan, Singapore, and the United States principally in the form of cash grants and tax credits. These incentives primarily relate to capital expenditures and may be subject to reimbursement if certain conditions are not met or maintained. The conditions attached to these incentives require us to incur expenditures related to the construction of new manufacturing facilities, the purchase and installation of specialized tools and equipment, R&D expenditures, meet and/or maintain operational metrics, and/or maintain certain levels of fixed asset investment or employee headcount during the incentive terms. Government incentives related to capital expenditures have reduced property, plant and equipment by $10.93 billion as of September 3, 2026, of which $6.43 billion pertained to 2026 expenditures. In 2026, operating income benefited by $901 million (approximately 78% in COGS and 22% in R&D) from government incentives that reduced depreciation expense and other operating incentives, which offset against the related expense. The line items on the balance sheet affected by government incentives were as follows: As ofSeptember 3, 2026August 28, 2025 Receivables$3,319 $1,572 Other noncurrent assets2,122 914 Noncurrent unearned government incentives786 1,018 86 Table of Contents In addition to the receivables and other noncurrent assets in the table above and cash incentives already received, we had commitments from various governmental entities, subject to achievement of certain performance conditions. U.S. CHIPS Act Funding Agreements On December 9, 2024, we entered into direct funding agreements with the U.S. Department of Commerce for up to $6.1 billion in direct funding pursuant to the CHIPS Act for a planned fab in Boise, Idaho and two planned fabs in Clay, New York. In June 2025, we entered into amendments to the direct funding agreements to add a second planned fab in Boise, Idaho and allocated certain award funding from the $6.1 billion grants previously awarded to the second planned Idaho fab. The direct funding for up to $6.1 billion remains unchanged. In 2025, we also entered into a direct funding agreement with the U.S. Department of Commerce for up to $275 million in direct funding for our fab in Manassas, Virginia. The direct funding agreement for our fab in Virginia is substantially similar to those for our fabs in Idaho and New York. The grants under the funding agreements represent total CHIPS Act grants of up to $6.4 billion in connection with our U.S. manufacturing expansion and modernization projects. Excluding the receivables and other noncurrent assets in the table above and cash incentives already received, the remaining unrecognized commitment related to the total CHIPS Act grants was $4.9 billion as of September 3, 2026. Funding will be based on the achievement of construction, tool installation, and wafer production milestones. We retain discretion with respect to capacity and production volume ramp of each project. The agreements contain representations, warranties, and covenants that relate to compliance with requirements for awards provided for in the CHIPS Act. In addition, the agreements include certain events of default and related rights and remedies, including clawbacks related to the failure to complete a project by an agreed upon completion date, violation of CHIPS Act restrictions on certain activities involving foreign countries and entities of concern, and impermissible use or disposition of a project. We are permitted to make customary and ordinary course recurring dividends (and reasonable ordinary course increases thereof) consistent with our past practice. There are restrictions on our payment of special and one-time dividends during the five-year period following the Idaho and New York award date of December 9, 2024. Share repurchases are permitted during the first two years of such five-year period up to amounts specified in the funding agreements to help offset the dilutive effects of employee stock compensation or as otherwise permitted by the U.S. Department of Commerce. During the final three years of such five-year period, stock repurchases are subject to financial and other conditions, including limitations based on free cash flow, net of CHIPS Act grant incentives received with respect to capital expenditures and net of dividends paid, each as defined in the direct funding agreements. We may be required to pay upside sharing amounts for a period of up to ten years following the first year in which the cumulative cash flow from a project is positive, if cumulative cash flows from the project exceed a threshold level that is at a significant premium to the baseline projection. The upside sharing amount would equal a modest sharing percentage of the excess cash flows above the threshold level, but not to exceed 75% of award disbursements for a project, after considering any clawbacks or other repayments. In addition to the $4.9 billion commitment amount above, we receive an investment tax credit on qualified investments in U.S. semiconductor manufacturing under the CHIPS Act. The One Big Beautiful Bill Act increased the investment tax credit from 25% to 35% on qualified investments. As qualified investments are made, we recognize investment tax credits in receivables or other noncurrent assets. We have also signed a non-binding term sheet with the state of New York that provides up to $5.5 billion in funding for the planned four-fab facility over the next 20-plus years through a combination of tax credits for qualified capital investments and incentives for eligible new job wages. Other Government Incentive Commitments We receive incentives for the construction of a new assembly and test facility in Gujarat, India, representing 50% of the total project cost from the Indian central government and 20% of the total project cost from the state of Gujarat. The remaining unrecognized commitment was for up to 102 billion Indian rupees (approximately $1.1 billion) as of September 3, 2026. 87 | 2026 10-K Table of Contents We also receive incentives from the Japanese Ministry of Economy, Trade and Industry to support the production of DRAM using EUV lithography and to modernize our Hiroshima, Japan manufacturing facility. The remaining unrecognized commitment was for up to 536 billion Japanese yen (approximately $3.4 billion) as of September 3, 2026. In November 2025, we finalized an incentive arrangement for the expansion of our Singapore manufacturing facilities, followed by a second arrangement in April 2026, for the expansion of our Singapore R&D. Under both arrangements, we will receive government support for qualified capital spending and labor costs. The incentive arrangements may be subject to reduction, recapture, or termination if certain conditions are not met. Terms and conditions are subject to the confidentiality provisions of the incentive arrangements. Note 16. Revenue and Customer Contract Liabilities Revenue by Technology For the year ended202620252024 DRAM$100,679 $28,578 $17,603 NAND31,785 8,503 7,227 Other (primarily NOR) 724 297 281 $133,188 $37,378 $25,111 See Note 20. Segment and Other Information for disclosure of disaggregated revenue by market segment. Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers at an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Contracts with certain of our customers are short-term in duration. We also have strategic customer agreements structured as take-or-pay agreements, with binding commitments for specific contractually enforceable volumes over the multi-year contract terms. Pricing for our contracts is either fixed or periodically negotiated, with the majority of the strategic customer agreements having pricing that is subject to minimum and maximum bands. As of September 3, 2026, the transaction price allocated to our remaining performance obligations was approximately $134 billion, of which $13 billion has been recognized as contract liabilities. Contract liabilities primarily consisted of customer deposits associated with strategic customer agreements. Nearly all of the deposits are scheduled to be repaid between 2029 and 2031. Approximately one-fourth of the remaining performance obligations as of September 3, 2026 are expected to be recognized as revenue over the next twelve months. The remaining performance obligations are expected to be fully recognized within the next five years. As of August 28, 2025, our remaining performance obligations were not material. Our remaining performance obligations are based on expected purchases to satisfy committed volumes and minimum pricing and are not expected to be indicative of future revenue under these contracts. We have excluded agreements from our remaining performance obligations that do not have either fixed pricing or price bands as the related consideration is variable at contract inception. As a practical expedient, we have excluded contracts that have an original term of one year or less from remaining performance obligations. Certain strategic customer agreements also include terms requiring our customers to maintain letters of credit with third-party financial institutions. Our right to access letters of credit is contingent upon the occurrence of specified events of default or breach by our customers. Letters of credit are not recognized as revenue unless an event of default or breach has occurred. The aggregate amount of letters of credit issued, or contractually committed to be issued, by third-party financial institutions was $7 billion as of September 3, 2026, which represented the maximum potential proceeds available to us in the event of customer default or breach. In the event of customer default or breach, our contractual recovery rights may include proceeds from letters of credit, rights to decrement customer deposits and other contractual remedies. As of September 3, 2026 and August 28, 2025, other current liabilities included $4.32 billion and $1.19 billion, respectively, for estimates of consideration payable to customers, including pricing adjustments and returns. 88 Table of Contents Note 17. Other Operating (Income) Expense, Net For the year ended202620252024 Patent license charges$500 $57 $ Patent cross-license agreement gain (200) Other67 43 (50) $567 $100 $(250) Note 18. Income Taxes Our income tax (provision) benefit consisted of the following: For the year ended202620252024 Income before income taxes and equity in net income (loss) of equity method investees U.S.$4,819 $686 $544 Foreign94,852 8,968 696 $99,671 $9,654 $1,240 Income tax (provision) benefit Current U.S. federal$(782)$(275)$(82) State(272)(15)(1) Foreign(14,180)(670)(333) (15,234)(960)(416) Deferred U.S. federal522 (118)18 State46 Foreign(95)(46)(53) 473 (164)(35) Income tax (provision) benefit$(14,761)$(1,124)$(451) In 2026, we adopted ASU 2023-09, Improvements to Income Tax Disclosure, on a prospective basis. The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate for the year ended September 3, 2026: (20,931)21.0 % State taxes, net of federal benefit(1) 0.2 % Foreign effects(6.0)% Other % Other foreign jurisdictions0.3 % Other(2) (0.7)% Income tax (provision) benefit (14,761)14.8 % (1)State taxes in Illinois made up the majority of the tax effects for 2026. 89 | 2026 10-K Table of Contents (2)Includes the tax effects of nontaxable or nondeductible items, tax credits, impacts of cross border tax effects, and changes in unrecognized tax benefits. The table below presents required disclosures prior to the adoption of ASU 2023-09 and reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate for the years ended August 28, 2025 and August 29, 2024: For the year ended20252024 U.S. federal income tax (provision) benefit at statutory rate $(2,027)21.0 %$(260)21.0 % U.S. tax on foreign operations(476)4.9 (7)0.6 Change in valuation allowance36 (0.4)(59)4.8 Change in unrecognized tax benefits(23)0.2 (41)3.3 Foreign tax rate differential1,132 (11.7)(214)17.2 Research and development tax credits208 (2.2)76 (6.1) State taxes, net of federal benefit(7)0.1 12 (1.0) Other33 (0.3)42 (3.4) Income tax (provision) benefit$(1,124)11.6 %$(451)36.4 % The table below provides the updated requirements of ASU 2023-09 for cash paid for income taxes, net of refunds: 275 State(1) Foreign Other jurisdictions Total cash paid for income taxes, net of refunds1,254 (1) State taxes in California made up the majority of the tax effects for 2026. We operate in a number of jurisdictions outside the United States, including Singapore, where we have tax incentive arrangements. These incentives expire, in whole or in part, at various dates through 2034 and are conditional, in part, upon meeting certain business operations and employment thresholds. For 2026, tax incentive arrangements in Singapore reduced our income tax provision by $11.22 billion. This benefit was largely offset by $9.03 billion of qualified domestic minimum top-up taxes resulting from Singapore s implementation of the OECD Pillar Two framework. Accordingly, the net benefit of tax incentive arrangements, primarily Singapore, to our income tax provision was $2.21 billion (benefiting our diluted earnings per share by $1.93). For 2025, tax incentive arrangements, primarily Singapore, reduced our income tax provision by $1.05 billion (benefiting our diluted earnings per share by $0.93). As a result of the low level of profitability and geographic mix of income, the benefit from tax incentive arrangements was not material for 2024. Other noncurrent liabilities included $9.82 billion and $648 million related to income taxes payable as of September 3, 2026 and August 28, 2025, respectively. As of September 3, 2026, certain non-U.S. subsidiaries had undistributed earnings that are deemed to be indefinitely reinvested. A provision has not been recognized to the extent that distributions from such subsidiaries would be subject to additional foreign withholding or state income tax. Determination of the amount of unrecognized deferred tax liabilities related to investments in these foreign subsidiaries is not practicable. 90 Table of Contents Deferred income taxes reflect the net tax effects of temporary differences between the bases of assets and liabilities for financial reporting and income tax purposes as well as carryforwards. Deferred tax assets and liabilities consist of the following: As ofSeptember 3, 2026August 28, 2025 Deferred tax assets Net operating loss and tax credit carryforwards$737 $1,016 Accrued salaries, wages, and benefits529 203 Operating lease liabilities140 192 Inventories119 25 Property, plant, and equipment63 Other202 37 Gross deferred tax assets1,790 1,473 Less valuation allowance(581)(634) Deferred tax assets, net of valuation allowance1,209 839 Deferred tax liabilities Right-of-use assets(108)(163) Other(172)(112) Deferred tax liabilities(280)(275) Net deferred tax assets$929 $564 As of September 3, 2026, and August 28, 2025, we had a valuation allowance of $581 million and $634 million, respectively, against our net deferred tax assets, primarily related to carryforwards in Malaysia and U.S. states. As of September 3, 2026, we had net operating loss carryforwards of $1.68 billion, of which $1.46 billion in Malaysia can be carried forward indefinitely and the remainder expires between 2027 and 2046. As of September 3, 2026, we had tax credit carryforwards of $513 million, of which $100 million can be carried forward indefinitely and the remainder expires between 2027 and 2046. Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits: For the year ended202620252024 Beginning unrecognized tax benefits$735 $716 $744 Increases related to tax positions from prior years17 11 2 Increases related to prior year tax positions taken in current year 20 Increases related to tax positions taken in current year64 55 54 Decreases related to tax positions from prior years(4)(8)(89) Decreases related to settlement with tax authorities (15) Reductions due to lapsed statutes of limitations (17)(39) Ending unrecognized tax benefits$795 $735 $716 As of September 3, 2026, gross unrecognized tax benefits were $795 million, which would have an impact of approximately $629 million on our effective tax rate in the future, if recognized. Amounts accrued for interest and penalties related to uncertain tax positions were not material for any period presented. The resolution of tax audits or expiration of statute of limitations could also reduce our unrecognized tax benefits. Our U.S. federal and state tax returns remain open to examination for 2018 through 2026. We are currently under audit by the Internal Revenue Service for our 2018 and 2019 tax years. In addition, tax returns that remain open to examination in Singapore, Taiwan, and Japan range from the years 2021 to 2026. 91 | 2026 10-K Table of Contents Note 19. Earnings Per Share For the year ended202620252024 Net income Basic and Diluted$84,969 $8,539 $778 Weighted-average common shares outstanding Basic1,127 1,116 1,105 Dilutive effect of equity compensation plans 16 9 13 Weighted-average common shares outstanding Diluted1,143 1,125 1,118 Earnings per share Basic$75.38 $7.65 $0.70 Diluted74.33 7.59 0.70 Antidilutive potential common shares excluded from the computation of diluted earnings per share, that could dilute basic earnings per share in the future, were as follows at the end of the periods shown: For the year ended202620252024 Equity compensation plans 6 3 Note 20. Segment and Other Information Segment information reported herein is consistent with the way our Chief Executive Officer, who is our Chief Operating Decision Maker ( CODM ), assesses the performance of our segments based on segment revenue, cost of goods sold, operating expenses, and operating income. The segment information reported herein is regularly provided to and reviewed and evaluated by our CODM to budget, forecast, and decide how to allocate resources for capital investments, human capital, and other strategic investments across our segments. We have the following four business units, which are our reportable segments: Cloud Memory Business Unit ( CMBU ): Focused on memory solutions for large hyperscale cloud customers, and HBM for all data center customers. Core Data Center Business Unit ( CDBU ): Focused on storage solutions for all data center customers, including data center SSDs and NAND components, and memory solutions for OEM data center, enterprise, and NeoCloud customers. Mobile and Client Business Unit ( MCBU ): Focused on memory and storage solutions for the mobile and client segments. Automotive and Embedded Business Unit ( AEBU ): Focused on memory and storage solutions for the automotive, industrial, and consumer segments. Our other operations do not meet the thresholds of a reportable segment and are reported under All Other. Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. Certain income and expenses are not allocated to segments because our CODM does not consider these amounts in the assessment of the performance of our segments. The unallocated amounts consisted primarily of stock-based compensation. Additionally, the unallocated amounts included $500 million of patent license charges in other operating (income) expense, net in 2026 and a $987 million benefit in cost of goods sold in 2024 from the sale of inventories that had been written down to their net realizable value in 2023. 92 Table of Contents For the year ended 2026CMBUCDBUMCBU AEBUAll OtherUnallocated Total Revenue$43,085 $37,592 $36,601 $15,886 $24 $ $133,188 Cost of goods sold8,802 6,031 6,413 3,891 19 528 25,684 Gross margin34,283 31,561 30,188 11,995 5 (528)107,504 Research and development2,510 1,648 550 443 1 498 5,650 Selling, general, and administrative549 374 430 335 259 1,947 Other operating (income) expense, net(1) 2 566 567 Operating income$31,225 $29,539 $29,208 $11,217 $2 $(1,851)$99,340 For the year ended 2025CMBUCDBUMCBU AEBUAll OtherUnallocated Total Revenue$13,524 $7,229 $11,859 $4,753 $13 $ $37,378 Cost of goods sold5,867 3,995 8,650 3,566 14 413 22,505 Gross margin7,657 3,234 3,209 1,187 (1)(413)14,873 Research and development1,315 864 836 435 348 3,798 Selling, general, and administrative213 188 390 195 219 1,205 Other operating (income) expense, net 2 2 96 100 Operating income$6,129 $2,180 $1,981 $557 $(1)$(1,076)$9,770 For the year ended 2024CMBUCDBUMCBU AEBUAll OtherUnallocated Total Revenue$3,792 $4,984 $11,667 $4,631 $37 $ $25,111 Cost of goods sold2,677 3,638 10,222 3,598 20 (657)19,498 Gross margin1,115 1,346 1,445 1,033 17 657 5,613 Research and development769 960 994 425 282 3,430 Selling, general, and administrative107 139 485 186 (1)213 1,129 Other operating (income) expense, net(5)(8)(33)(10) (194)(250) Operating income$244 $255 $(1)$432 $18 $356 $1,304 Depreciation and amortization expense included in operating income was as follows: For the year ended 202620252024 CMBU$3,335 $2,260 $1,112 CDBU2,237 1,530 1,434 MCBU2,490 3,177 3,762 AEBU1,431 1,375 1,447 All Other6 5 7 Unallocated4 5 18 $9,503 $8,352 $7,780 We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments. As of September 3, 2026 and August 28, 2025, CMBU, CDBU, MCBU, and AEBU had goodwill of $654 million, $109 million, $284 million, and $103 million, respectively. 93 | 2026 10-K Table of Contents Note 21. Certain Concentrations Our business units are based on market segments. See Note 20. Segment and Other Information for disclosure of disaggregated revenue by market segment. No customer accounted for 10% or more of total revenue in 2026. Revenue from one customer was 17% (primarily included in the CMBU segment) of total revenue for 2025. Revenue from one customer was 10% (primarily included in the MCBU, AEBU, and CMBU segments) of total revenue for 2024. We generally have multiple sources of supply for our raw materials and production equipment; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards and, in some cases, materials or production equipment are provided by a single supplier. Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-income securities, trade receivables, share repurchase, and derivative contracts. We invest in high-credit-quality issuers and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor and monitor credit risk on an ongoing basis. A concentration of credit risk may exist with respect to receivables of certain customers. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers to mitigate credit risk. Historically, we have not experienced material losses on receivables. A concentration of risk may also exist with respect to our derivative hedging programs as the number of counterparties to our hedges is limited and the notional amounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions and through entering into master netting arrangements. Note 22. Geographic Information Revenue based on the geographic location of our customers headquarters was as follows: For the year ended202620252024 U.S. $91,323 $24,113 $13,168 Taiwan16,950 5,672 4,708 Mainland China (excluding Hong Kong)8,338 2,639 3,045 Hong Kong6,289 1,138 1,071 Other Asia Pacific5,777 1,913 1,330 Japan2,066 895 840 Europe 1,716 625 818 Other729 383 131 $133,188 $37,378 $25,111 Long-lived assets by geographic area consisted of property, plant, and equipment and operating lease right-of-use assets and were as follows: As ofSeptember 3, 2026August 28, 2025 Taiwan$27,613 $18,965 U.S.14,463 8,445 Singapore12,345 10,669 Japan7,247 7,038 Malaysia1,184 1,124 India609 449 China473 544 Other97 92 $64,031 $47,326 94 Table of Contents Report of Independent Registered Public Accounting Firm To the Board of Directors and Shareholders of Micron Technology, Inc. Opinions on the Financial Statements and Internal Control over Financial Reporting We have audited the accompanying consolidated balance sheets of Micron Technology, Inc. and its subsidiaries (the Company ) as of September 3, 2026 and August 28, 2025, and the related consolidated statements of operations and comprehensive income, of changes in equity and of cash flows for each of the three years in the period ended September 3, 2026, including the related notes (collectively referred to as the consolidated financial statements ). We also have audited the Company's internal control over financial reporting as of September 3, 2026, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of September 3, 2026 and August 28, 2025, and the results of its operations and its cash flows for each of the three years in the period ended September 3, 2026 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 3, 2026, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO. Basis for Opinions The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions. Definition and Limitations of Internal Control over Financial Reporting A company s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company s assets that could have a material effect on the financial statements. 95 | 2026 10-K Table of Contents Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Critical Audit Matters The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates. Revenue Recognition As described in Note 1 to the consolidated financial statements, revenue is primarily recognized at a point in time when control of the promised goods is transferred to customers at an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods. Contracts with certain customers are short-term in duration. The Company also has strategic customer agreements structured as take-or-pay agreements, with binding commitments for specific contractually enforceable volumes over the multi-year contract terms. For all contracts, payments are generally due shortly after delivery. The Company estimates a liability for returns using the expected value method based on historical returns. In addition, the Company generally offers price protection to its distributors, which is a form of variable consideration that decreases the transaction price. The Company uses the expected value method, based on historical price adjustments and current pricing trends, to estimate the amount of revenue recognized from sales to distributors. Differences between the estimated and actual amounts are recognized as adjustments to revenue. The Company recorded total revenue of $133,188 million for the year ended September 3, 2026. The principal consideration for our determination that performing procedures relating to revenue recognition is a critical audit matter is a high degree of auditor effort in performing procedures related to the Company s revenue recognition. Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the revenue recognition process. These procedures also included, among others, (i) reading a sample of customer agreements for relevant contractual terms; (ii) evaluating revenue recognized by testing the issuance and settlement of invoices and credit memos, tracing transactions not settled to a detailed listing of accounts receivable, and testing the completeness and accuracy of data provided by management; (iii) confirming, on a sample basis, outstanding customer invoice balances as of year-end and, for confirmations not returned, obtaining and inspecting source documents, including executed contracts, purchase orders, invoices, proof of shipment or delivery, as applicable, and subsequent cash receipts, as applicable; and (iv) testing revenue adjustments related to distributor price protection, on a sample basis, by obtaining and inspecting source documents, which included support for the nature and amount of the adjustments. /s/ PricewaterhouseCoopers LLP San Jose, California October 9, 2026 We have served as the Company s auditor since 1984. 96 Table of Contents ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None. ITEM 9A. CONTROLS AND PROCEDURES An evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act )) as of the end of the period covered by this report. Based upon that evaluation, the principal executive officer and principal financial officer concluded that those disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized, and reported within the time periods specified in the SEC s rules and forms and that such information is accumulated and communicated to our management, including the principal executive officer and principal financial officer, to allow timely decisions regarding disclosure. During the fourth quarter of 2026, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Management s Report on Internal Control Over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on our financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that our internal control over financial reporting was effective as of September 3, 2026. The effectiveness of our internal control over financial reporting as of September 3, 2026 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report, which is included in Part II, Item 8, of this Annual Report on Form 10-K. 97 | 2026 10-K Table of Contents ITEM 9B. OTHER INFORMATION Securities Trading Plans of Directors and Executive Officers The following officer, as defined in Rule 16a-1(f) of the Exchange Act, adopted a Rule 10b5-1 trading arrangement as defined in Item 408 of Regulation S-K, during the last fiscal quarter. On July 17, 2026, Scott DeBoer, our President and Chief Technology and Products Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale of an aggregate of up to 85,632 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The first date that sales of any shares are permitted to be sold under the trading arrangement is October 16, 2026, and subsequent sales under the trading arrangement may occur on a regular basis for the duration of the trading arrangement. The trading arrangement will terminate no less than one year from the date the plan is entered into, or earlier if all transactions under the trading arrangement are completed. No other directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, as defined in Item 408 of Regulation S-K, during the last fiscal quarter. ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS Not applicable. PART III Certain information concerning our executive officers is included under the caption, Information About Our Executive Officers in Part I, Item 1 of this report. Other information required by Items 10, 11, 12, 13, and 14 will be contained in our 2026 Proxy Statement which will be filed with the SEC within 120 days after September 3, 2026 and is incorporated herein by reference. ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE ITEM 11. EXECUTIVE COMPENSATION ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES PART IV ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULE 98 Table of Contents (a) The following documents are filed as part of this report: 1Financial Statements: See our consolidated financial statements under Item 8. 2Certain Financial Statement Schedules have been omitted since they are either not required, not applicable, or the information is otherwise included. 3Exhibits. See Index to Exhibits within Item 15 below. 99 | 2026 10-K Table of Contents Index to Exhibits Exhibit NumberDescription of ExhibitFiled HerewithFormPeriod EndingExhibit/ AppendixFiling Date 3.1Restated Certificate of Incorporation of the Registrant 10-Q2/26/263.13/19/26 3.2Amended and Restated Bylaws of Registrant as of July 17, 2025 8-K 3.1 7/18/25 4.1Indenture, dated as of February 6, 2019, by and between Micron Technology, Inc. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as Trustee 8-K4.12/6/19 4.2First Supplemental Indenture, dated as of February 6, 2019, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee 8-K4.22/6/19 4.3Form of Note for Micron Technology, Inc. s 5.327% Senior Notes due 2029 (included in Exhibit 4.2) 8-K4.52/6/19 4.4 Second Supplemental Indenture, dated as of July 12, 2019, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee 8-K4.27/12/19 4.5Form of Note for Micron Technology, Inc. s 4.663% Senior Notes due 2030 (included in Exhibit 4.4) 8-K4.47/12/19 4.6Fourth Supplemental Indenture, dated as of November 1, 2021, by and between Micron Technology, Inc. and U.S. Bank National Association, as Trustee 8-K4.211/1/21 4.7Form of Note for Micron Technology, Inc. s 2.703% Senior Notes due 2032 (included in Exhibit 4.6) 8-K4.311/1/21 4.8Form of Note for Micron Technology, Inc. s 3.366% Senior Notes due 2041 (included in Exhibit 4.6) 8-K4.411/1/21 4.9Form of Note for Micron Technology, Inc. s 3.477% Senior Notes due 2051 (included in Exhibit 4.6) 8-K4.511/1/21 4.10Description of Registrant s Securities 10-K 9/1/224.12 10/7/22 4.11Fifth Supplemental Indenture, dated as of October 31, 2022, by and between Micron Technology, Inc. and U.S. Bank Trust Company, National Association, as Trustee 8-K 4.2 10/31/22 4.12Form of Note for Micron Technology, Inc. s 6.750% Senior Notes due 2029 (included in Exhibit 4.11) 8-K 4.3 10/31/22 4.13Sixth Supplemental Indenture, dated as of February 9, 2023, by and between Micron Technology, Inc. and U.S. Bank Trust Company, National Association, as Trustee 8-K 4.3 2/9/23 4.14Form of Note for Micron Technology, Inc. s 5.875% Senior Notes due 2033 (included in Exhibit 4.13) 8-K 4.5 2/9/23 4.15Seventh Supplemental Indenture, dated as of April 11, 2023, by and between Micron Technology, Inc. and U.S. Bank Trust Company, National Association, as Trustee 8-K 4.2 4/11/23 4.16Form of Note for Micron Technology, Inc. s 5.375% Senior Notes due 2028 (included in Exhibit 4.15) 8-K 4.3 4/11/23 4.17Form of Note for Micron Technology, Inc. s 5.875% Senior Notes due 2033 (included in Exhibit 4.15) 8-K 4.4 4/11/23 4.18Eighth Supplemental Indenture, dated as of January 12, 2024, by and between Micron Technology, Inc. and U.S. Bank Trust Company, National Association, as Trustee 8-K 4.2 1/12/24 4.19Form of Note for Micron Technology, Inc. s 5.30% Senior Notes due 2031 (incorporated by reference from Exhibit 4.18 hereto) 8-K 4.3 1/12/24 4.20Ninth Supplemental Indenture, dated as of January 16, 2025, by and between Micron Technology, Inc. and U.S. Bank Trust Company, National Association, as Trustee 8-K 4.2 1/16/25 4.21Form of Note for Micron Technology, Inc. s 5.80% Senior Notes due 2035 (included in Exhibit 4.20) 8-K 4.3 1/16/25 100 Table of Contents Exhibit NumberDescription of ExhibitFiled HerewithFormPeriod EndingExhibit/ AppendixFiling Date 4.22Tenth Supplemental Indenture, dated as of April 29, 2025, by and between Micron Technology, Inc. and U.S. Bank Trust Company, National Association, as Trustee 8-K 4.2 4/29/25 4.23Form of Note for Micron Technology, Inc. s 5.65% Senior Notes due 2032 (included in Exhibit 4.22) 8-K 4.3 4/29/25 4.24Form of Note for Micron Technology, Inc. s 6.05% Senior Notes due 2035 (included in Exhibit 4.22) 8-K 4.4 4/29/25 10.1*Micron Technology, Inc. Executive Officer Performance Incentive Plan DEF 14AB12/7/17 10.2*Amended and Restated 2004 Equity Incentive Plan 10-Q 12/1/2210.1 12/22/22 10.3*2004 Equity Incentive Plan Forms of Agreement and Terms and Conditions 10-Q 12/1/2210.2 12/22/22 10.4*Amended and Restated 2007 Equity Incentive Plan DEF 14AA12/1/20 10.5*2007 Equity Incentive Plan Forms of Agreement and Terms and Conditions 10-Q12/1/2210.3 12/22/22 10.6*Form of Indemnification Agreement between the Registrant and its officers and directors 10-Q2/27/2510.5 3/21/25 10.7*Form of Severance Agreement 8-K99.211/1/07 10.8*Deferred Compensation Plan, as amended 10-K 8/31/2310.10 10/6/23 10.9*Amended and Restated Executive Agreement by and between Micron Technology, Inc. and Sanjay Mehrotra 10-K 9/1/2210.11 10/7/22 10.10*Severance Benefits for Sumit Sadana 10-Q11/30/1710.7012/20/17 10.11*Form of Amendment to Executive/Severance Agreement 8-K99.111/13/17 10.12*Severance Benefits for Manish Bhatia 10-Q11/30/1710.7412/20/17 10.13*Micron Technology, Inc. Employee Stock Purchase Plan, as amended and restated 10-Q6/2/2210.17/1/22 10.14*Severance Benefits for Mark Murphy 10-Q6/2/2210.37/1/22 10.15*Form of Consent for Named Executive Officers 10-Q 3/2/2310.53/29/23 10.16*Executive Officer Cash Severance Policy 10-Q 11/30/2310.112/21/23 10.17*Severance Policy Acknowledgement Letter for Sanjay Mehrotra 10-Q 11/30/2310.212/21/23 10.18*Amended and Restated Severance Agreement by and between Micron Technology, Inc. and Scott J. DeBoer 10-Q 11/30/2310.312/21/23 10.19Term Loan Credit Agreement, dated as of January 17, 2025, by and among Micron Technology, Inc., as borrower, PNC Bank, National Association, as administrative agent, the other agents party thereto, and each financial institution party from time to time thereto 10-Q 2/27/2510.1 3/21/25 10.20*Amended and Restated 2007 Equity Incentive Plan Forms of Agreement and Terms and Conditions X 10.21*2025 Equity Incentive Plan 10-Q 2/27/2510.2 3/21/25 10.22*2025 Equity Incentive Plan Forms of Agreement and Terms and Conditions X 10.23*2025 Director Compensation Plan 10-Q 2/27/2510.6 3/21/25 10.24 Direct Funding Agreement, dated December 9, 2024, by and between Micron Idaho Semiconductor Manufacturing (Triton) LLC and U.S. Department of Commerce 10-Q 2/27/2510.7 3/21/25 10.25 Direct Funding Agreement, dated December 9, 2024, by and between Micron New York Semiconductor Manufacturing LLC and U.S. Department of Commerce 10-Q 2/27/2510.8 3/21/25 10.26Guarantee and Equity Contribution Agreement, by and between Micron Technology, Inc. and U.S. Department of Commerce 10-Q 2/27/2510.9 3/21/25 101 | 2026 10-K Table of Contents Exhibit NumberDescription of ExhibitFiled HerewithFormPeriod EndingExhibit/ AppendixFiling Date 10.27Credit Agreement, dated as of March 12, 2025, by and among Micron Technology, Inc., as borrower, HSBC Bank USA, National Association, as administrative agent, the other agents party thereto, and each financial institution party from time to time thereto 10-Q 2/27/2510.10 3/21/25 10.28 Amendment No. 1 to Direct Funding Agreement, dated January 17, 2025, by and between Micron Idaho Semiconductor Manufacturing (Triton) LLC and U.S. Department of Commerce 10-Q 2/27/2510.11 3/21/25 10.29 Amendment No. 1 to Direct Funding Agreement, dated January 17, 2025, by and between Micron New York Semiconductor Manufacturing LLC and U.S. Department of Commerce 10-Q 2/27/2510.12 3/21/25 10.30 Amendment No. 2 to Direct Funding Agreement, dated June 11, 2025, by and between Micron Idaho Semiconductor Manufacturing (Triton) LLC and U.S. Department of Commerce 10-K8/28/2510.3210/3/25 10.31 Amendment No. 2 to Direct Funding Agreement, dated June 11, 2025, by and between Micron New York Semiconductor Manufacturing LLC and U.S. Department of Commerce 10-K8/28/2510.3310/3/25 10.32 Waiver and Amendment No. 3 to Direct Funding Agreement, dated February 27, 2026, by and between Micron Idaho Semiconductor Manufacturing (Triton) LLC and U.S. Department of Commerce 10-Q5/28/2610.106/25/26 10.33 Waiver and Amendment No. 3 to Direct Funding Agreement, dated February 27, 2026, by and between Micron New York Semiconductor Manufacturing LLC and U.S. Department of Commerce 10-Q5/28/2610.206/25/26 10.34Amendment and Restated Guarantee and Equity Contribution Agreement, dated June 11, 2025, by and between Micron Technology, Inc. and the U.S. Department of Commerce 10-K8/28/2510.3410/3/25 19.1Insider Trading Policy of the Registrant X 21.1Subsidiaries of the Registrant X 23.1Consent of Independent Registered Public Accounting Firm X 31.1Rule 13a-14(a) Certification of Chief Executive Officer X 31.2Rule 13a-14(a) Certification of Chief Financial Officer X 32.1Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350 X 32.2Certification of Chief Financial Officer Pursuant to 18 U.S.C. 1350 X 97.1Compensation Recoupment (Clawback) Policy, as amended and restated 10-K 8/31/2397.110/6/23 101.INSInline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documentX 101.SCHInline XBRL Taxonomy Extension Schema DocumentX 101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentX 101.DEFInline XBRL Taxonomy Extension Definition Linkbase DocumentX 101.LABInline XBRL Taxonomy Extension Label Linkbase DocumentX 101.PREInline XBRL Taxonomy Extension Presentation Linkbase DocumentX 104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) X * Indicates management contract or compensatory plan or arrangement. Certain portions of this exhibit have been redacted because they are both not material and is the type that the Registrant treats as private or confidential. The Registrant hereby agrees to furnish supplementally to the Securities and Exchange Commission, upon its request, an unredacted copy of this exhibit. 102 Table of Contents ITEM 16. FORM 10-K SUMMARY None. 103 | 2026 10-K Table of Contents SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Micron Technology, Inc. DateOctober 9, 2026By:/s/ Mark Murphy Mark Murphy Executive Vice President and Chief Financial Officer (Principal Financial Officer) Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. SignatureTitleDate /s/ Sanjay MehrotraChairman andOctober 9, 2026 (Sanjay Mehrotra)Chief Executive Officer (Principal Executive Officer) /s/ Mark MurphyExecutive Vice President andOctober 9, 2026 (Mark Murphy)Chief Financial Officer (Principal Financial Officer) /s/ Scott AllenCorporate Vice President andOctober 9, 2026 (Scott Allen)Chief Accounting Officer (Principal Accounting Officer) /s/ Lynn A. Dugle Lead Independent Director October 9, 2026 (Lynn A. Dugle) /s/ Alexis Black Bj rlinDirectorOctober 9, 2026 (Alexis Black Bj rlin) /s/ Steven J. Gomo DirectorOctober 9, 2026 (Steven J. Gomo) /s/ Linnie M. Haynesworth DirectorOctober 9, 2026 (Linnie M. Haynesworth) /s/ T. Mark Liu DirectorOctober 9, 2026 (T. Mark Liu) /s/ A. Christine Simons DirectorOctober 9, 2026 (A. Christine Simons) /s/ Robert H. Swan DirectorOctober 9, 2026 (Robert H. Swan) /s/ MaryAnn WrightDirectorOctober 9, 2026 (MaryAnn Wright) 104